Pentwater Capital Management LP - CALLIDITAS THERAPEUTICS AB ownership

CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 11 filers reported holding CALLIDITAS THERAPEUTICS AB in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of CALLIDITAS THERAPEUTICS AB
ValueSharesWeighting
Q3 2021$995,000
-32.5%
46,000
-8.0%
0.01%
-16.7%
Q2 2021$1,473,000
+6.8%
50,0000.0%0.01%
-7.7%
Q1 2021$1,379,000
-18.0%
50,0000.0%0.01%
-35.0%
Q4 2020$1,681,000
+14.7%
50,000
-18.1%
0.02%
+5.3%
Q3 2020$1,466,000
-4.2%
61,084
-7.4%
0.02%
-29.6%
Q2 2020$1,531,00066,0000.03%
Other shareholders
CALLIDITAS THERAPEUTICS AB shareholders Q4 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 200,000$6,724,0002.33%
BVF INC/IL 750,000$25,493,0001.00%
Logos Global Management LP 300,000$10,086,0000.86%
Vivo Capital, LLC 311,030$10,457,0000.47%
HHLR ADVISORS, LTD. 1,047,687$35,611,0000.28%
Pentwater Capital Management LP 50,000$1,681,0000.02%
Point72 Asset Management, L.P. 102,748$3,454,0000.02%
DEUTSCHE BANK AG\ 70,236$2,361,0000.00%
MILLENNIUM MANAGEMENT LLC 20,484$696,0000.00%
JANE STREET GROUP, LLC 7,557$256,0000.00%
View complete list of CALLIDITAS THERAPEUTICS AB shareholders